MedPath

A clinical trial to study the effects of trichloroacetic acid in tympanic membrane perforation and in improvement of hearing.

Phase 3
Completed
Conditions
Health Condition 1: null- Tympanic Membrane Perforation
Registration Number
CTRI/2015/12/006423
Lead Sponsor
Government Medical College and Sir Takhtsinhji General Hospital Bhavnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.Patients with central perforation of tympanic membrane following infective or traumatic perforations of tympanic membrane.

2.Ear must be dry for at least 4 weeks.

3.Patient should have pure conductive type of hearing loss.

Exclusion Criteria

1.History of previous ear surgery

2.Attico-antral disease

3.Active discharge

4.Nasopharyngeal pathology

5.Eustachian tube dysfunction

6.Active rhinosinusitis

7.pure sensoryneural hearing loss

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvement in hearing and reduction in size of perforationTimepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
complete healing of tympanic membrane perforationTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath